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ABSTRACT 
Emergency contraception (EC) in Serbia is available in two products, one of which, 
Levonorgestel, has nonprescription status, and Ulipristal acetate is a prescription-only medicine. 
Considering their dispensing statuses, gynecologists and pharmacists are health care 
professionals (HCPs) with the widest impact on EC use. Yet little is known about their beliefs 
and practices regarding these medicines. We surveyed 166 gynecologists (during October 2012 - 
October 2013) and 452 community pharmacists (during January - April 2014). Results showed 
significant differences between these two groups, suggesting that provision of EC to users may 
be inconsistent. Gynecologists were more convinced than pharmacists that EC would reduce the 
abortion rate (86% vs. 53%, p < .001). However, they were more concerned than pharmacists 
that easy access to EC would cause less regular contraceptive use (66% vs. 29%, p < .001) and 
risky sexual behaviors: initiating sexual activity at a younger age (37% vs. 19%, p < .001) and 
having more sexual partners (33% vs. 12%, p < .001). Additionally, more pharmacists than 
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gynecologists (12% vs. 2%, p < .001) said they would not provide EC to anyone under any 
circumstance, even to victims of sexual assault. These results indicated a need for reevaluating 
and establishing official guidelines for dispensing practices. 
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INTRODUCTION 
Use of emergency contraception (EC) is a controversial issue in health care. It is administered 
postcoitally when regular contraception fails or is not used; therefore, it has some potential to 
reduce unintended pregnancies. Accurate and reliable information concerning numbers of 
abortions in Serbia is not available due to the lack of records from private clinics. According to 
official data 20,335 abortions were reported in 2012 (Institute of Public Health of Serbia 2013), 
though it is estimated that the true number is many times higher (Rasević and Sedlecky 2009). 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 L
eth
br
idg
e] 
at 
14
:52
 17
 A
pr
il 2
01
6 
Ac
ce
pte
d M
an
us
cri
pt
 
3 
These abortions were mainly a consequence of non-use of effective methods for pregnancy 
prevention (Rasević and Sedlecky 2009). The contraception use rate has been reported to be 
61%, of which only 21.5% used some modern method, such as oral contraceptives or intrauterine 
devices (UN DESA 2013). EC is available on the market in two products: Levonorgestel (LNG), 
with nonprescription status for those older than 16 years of age, and Ulipristal acetate (UPA), 
which can be dispensed only by prescription (Milosavljević, Ilić and Krajnović 2014). Yearly 
consumption of these products has been growing with 103,231 packs of LNG and 162 packs of 
UPA sold in 2012 (ALiMS 2012). 
Considering the dispensing statuses of these two EC drugs, both gynecologists and pharmacists 
may directly affect access to EC. Responsibilities of these health care professionals (HCPs) 
include providing prescriptions, dispensing the medicines and educating patients. However, in 
Serbia no officially approved clinical guidance documents are available for family planning; so, 
clinical practice can differ from one to another HCP. Also from investigations in other countries, 
it is evident that personal characteristics and beliefs of HCPs can influence their practice 
regarding EC and sometimes also lead to users being denied EC (Lawrence, Rasinski, Yoon and 
Curlin 2010, Hussainy et al. 2011, Bissell, Savageand and Anderson 2006, Ehrle and Sarker 
2011). A USA study (Lawrence, Rasinski, Yoon and Curlin 2010) showed that gynecologists 
who believed access to EC would cause risky behavior were more conservative in providing EC. 
Also male and religious physicians were more reluctant to offer EC. Similarly, personal beliefs, 
religion, age and gender were shown to be important factors related to pharmacists’ provision of 
EC in an Australian study (Hussainy et al. 2011). 
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Recently, the European Medicines Agency recommended non-prescription status for UPA 
(European Medicines Agency 2015). This change is expected to be implemented soon in Serbia 
as well, but no evidence has been provided to indicate if pharmacists are ready for that. To date, 
no data have been published of which we are aware on gynecologists’ and pharmacists’ attitudes 
and practices regarding EC in Serbia. Therefore, the primary objective of this study was to assess 
differences in beliefs of Serbian obstetricians-gynecologists (called ‘gynecologists’ in the 
remainder of the text) and community pharmacists about EC. The secondary objective was to 
determine which traits of HCPs were related to their beliefs regarding EC. 
METHODS 
A descriptive, cross-sectional survey, designed as a knowledge, attitude, and practice study was 
conducted with gynecologists and community pharmacists. This study protocol was approved by 
the Institutional Ethics Committee of the Faculty of Pharmacy of the University of Belgrade. 
Due to differences in organization and in working conditions of gynecologists and pharmacists, 
the data collection procedure varied between the two study groups. 
Gynecologists 
We distributed a questionnaire to a convenience sample of 550 gynecologists who attended six 
regional educational meetings of the Gynaecology and Obstetrics Section of the Serbian Medical 
Society between October 2012 and October 2013. Participation was voluntary and anonymous. 
Doctors working in all kinds of healthcare facilities (either in the public or the private sector) 
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5 
were present at the meetings and had the opportunity to partake in the survey. Information about 
the study was provided verbally and via an information sheet. Completing and returning the 
questionnaire was taken as informed consent. The attendees were asked not to complete the 
questionnaire more than once in the event that they already completed it at some previous 
conference. We received 183 completed questionnaires. The response rate was 33%. After 
excluding forms with missing main outcome variables, the final sample consisted of 166 surveys. 
Pharmacists 
The questionnaire was administered to members of the Pharmaceutical Chamber of Serbia 
through their official website (http://www.farmkom.rs) during the period January - April 2014. 
Information about the voluntary and anonymous nature of the study was provided via an 
information sheet. Completing the questionnaire was taken as informed consent. To reach non-
Internet users, the survey was also announced, and the link was provided in a journal published 
by the Chamber and distributed to all pharmacies. A total of 462 completed questionnaires were 
received and checked for pharmacists’ practice type and the presence of potential duplicates 
based on sociodemographic characteristics, date and exact time of questionnaire completion. No 
duplicates were identified. Pharmacists practicing in settings other than community pharmacies 
were excluded; thus, our sample consisted of 452 respondents. As we used an Internet survey, it 
was not possible to calculate a conventional response rate. Based on the Chamber’s data, they 
had 5,377 members on April 15th, 2014 (The Pharmaceutical Chamber of Serbia 2014); thus 452 
participants would be a participation rate of 8%. 
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Questionnaire 
The instrument used for data collection was a modified version of the questionnaire developed 
by Lawrence et al. (Lawrence, Rasinski, Yoon and Curlin 2010). With permission of the authors, 
the original questionnaire was translated from English into Serbian by two independent 
translators. After reconciliation, a back translation was performed by a third translator. The draft 
version was pre-tested on ten gynecologists selected randomly. This process was completed in 
accordance with the ISPOR (International Society for Pharmacoeconomics and Outcomes 
Research) Principles of Good Practice in translation and cultural adaptation process (Wild et al. 
2005). The same questions regarding EC were repeated in the questionnaire created for 
pharmacists and pre-tested on ten community pharmacists; no major changes were generated. 
HCPs' beliefs about EC were assessed by the following statements: “compared with women who 
are similar but do not have access to EC, women who have access to EC: (1) will have lower 
rates of unintended pregnancy; (2) will be less likely to use other contraceptive methods; (3) will 
initiate sexual activity at a younger age; and (4) will have more sexual partners”. HCPs rated 
their level of agreement using four-point Likert scales. We also asked HCPs to choose the option 
which best described their practice regarding EC, whether they offered it: “(1) to all women they 
believe are at risk of unplanned pregnancy, (2) only to women who tell them that they have had 
unprotected intercourse, (3) only to victims of sexual assault, (4) to nobody under any 
circumstances”. 
Information was gathered concerning the socio-demographic features of the participants, 
specifically, gender, age, region of residence, having children and marital status. 
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Statistical analysis 
Data were analyzed using the Statistical Package for Social Science Software (SPSS 22.0 for 
Windows, SPSS Inc., Chicago, IL, USA). First, descriptive statistics were calculated. Next, 
differences in socio-demographic characteristics by HCPs’ beliefs, as well as socio-demographic 
characteristics, HCPs’ beliefs and their practices pertaining to EC were analyzed using t-tests and 
chi-squared tests. Binary logistic regression was used to compute the independent associations of 
variables with HCPs’ beliefs and practices by calculating Odds ratios (ORs) with 95% 
confidence intervals (CI). Variables found to be associated with HCPs’ beliefs and practices in 
the bivariate analysis (p < .05) were included in multivariate logistic regression models. The 
multiple logistic regression models included the potential confounding variables: age, gender, 
marital status, having children and region. All independent variables were entered into the model 
at the same time. The association of variables was estimated as an adjusted odds ratio (aORs) 
with 95% CI. The Hosmer and Lemeshow test was used to assess model fit. Statistical 
significance was deemed to have been reached when the computed probability value was < .05. 
RESULTS 
Among the respondents, pharmacists tended to be significantly younger than gynecologists 
(Table 1). Also, significantly more women were included in the pharmacists group (p < .001), 
while significantly more gynecologists than pharmacists were in a relationship (p < .001) and 
had children (p < .001).  
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8 
A higher percentage of gynecologists (86%) than pharmacists (53%) believed that women with 
access to EC would have fewer unintended pregnancies. Gynecologists were more concerned 
than pharmacists that women with access to EC would be prone to risky behavior: not using 
other contraceptives (66% vs. 29%, p < .001), initiate sexual activity at a younger age (37% vs. 
19%, p < .001) and have more sexual partners (33% vs. 12%, p < .001) (Table 2).   
The majority of responders in both surveyed groups differed little in their dispensing practices. 
Just over half offered EC only to women after unprotected intercourse. A third offered it to all 
women at risk of unintended pregnancy. However, significantly more pharmacists than 
gynecologists (12% vs. 2%, p < .001) responded that they would not offer EC to anyone under 
any circumstance (Table 3). 
After taking gender, age, marital status and children into account, responders in Southern and 
Eastern Serbia were less likely to believe that use of EC would lower rates of  unintended 
pregnancy, but more likely to think that it would cause women to have more sexual partners than 
responders from other regions (Table 4). Pharmacists from Belgrade were less likely to consider 
that EC would cause the risky sexual behaviors of women initiating sexual activity at a younger 
age and having more sexual partners. After adjustment for age, marital status, children and 
region, male pharmacists were more likely to believe that women with access to EC would have 
more sexual partners. However, pharmacists’ practice did not differ by gender, age, region, 
marital status, having children and beliefs, so further logistic regressions were not performed. 
The unadjusted associations of gynecologists’ beliefs with age, marital status and children were 
not sustained in multiple logistic regression models (Table 5). Their practice variation by gender 
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9 
was observed in univariate analysis: compared to female gynaecologists, male gynecologists 
were more likely to offer EC only to women who tell them that they have had unprotected 
intercourse (OR 2.069, 95% CI 1.033-4.141, p = .040). After adjustment for confounding 
variables, multivariable logistic regression showed no significant gender difference in EC offer 
by male and female gynecologists (aOR 1.650, 95% CI 0.754-3.613, p = .210). The relation of 
belief to gynecologic practice was observed in univariate (OR 2.776, 95% CI 1.573-4.897, p < 
.001) and multivariable analysis (aOR 2.825, 95% CI 1.328-6.012, p = .007); gynecologists who 
believed that EC would reduce the number of unintended pregnancies were more than 2.5 times 
as likely not to offer EC or to offer it only to victims of sexual assault in univariate (OR 2.776, 
95% CI 1.573-4.897, p < .001) and multivariate analysis (aOR 2.825, 95% CI 1.328-6.012, p = 
.007). 
DISCUSSION 
This is the first study of which we are aware which has examined attitudes and practice regarding 
use of EC among Serbian gynecologists and pharmacists. It was performed just before the 
change in UPA prescription status to assess readiness of HCPs for this implementation. 
Information was gathered from HCPs residing in all regions of Serbia. 
Similar to results in the USA (Lawrence, Rasinski, Yoon and Curlin 2010), our results showed 
that both pharmacists and gynecologists expected EC to reduce the number of unintended 
pregnancies. Based on estimated EC efficacy in clinical trials (von Hertzen et al. 2002, Glasier et 
al. 2010), this conviction is quite understandable. However, the public health benefit of EC on 
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10 
the abortion rate has yet to be demonstrated. Paradoxically, the outcomes of studies in many 
countries have shown no changes in the rate of unintended pregnancies following the 
introduction of EC (Xiaoyu, Linan, Xiaolin and Anna 2005, Polis et al. 2007, Rodrigueza et al. 
2013). A community intervention study in Scotland (Glasier et al. 2004) on a population of 
around 85,000 women indicated no measurable relation to the abortion rate. Also a systematic 
review, which covered 10 countries, found that easy access to EC was not related to a decrease 
the number of unintended pregnancies or abortions (Raymond, Trussell and Polis 2007). In the 
light of results from these studies, it is surprising that 86% of gynecologists in our research, far 
more than pharmacists (53%), believed that access to EC would reduce unplanned pregnancy 
rates. It is possible that gynecologists overestimate the effectiveness of EC. 
The gynecologists in our study were more likely than pharmacists, as well as more likely than 
gynecologists who participated in research in the USA (Lawrence, Rasinski, Yoon and Curlin 
2010) to believe that EC would discourage women from using other contraceptive methods. 
Results from other studies also identified concerns of HCPs about risky contraceptive behavior 
related to increased availability of EC (Bissell, Savage and Anderson 2006, Ehrle and Sarker 
2011). However, studies with users showed that repeated EC use does not occur frequently 
(Rowlands et al. 2000, Abuabara et al. 2004). Also a meta-analysis of studies of providing EC 
found that greater access to EC was not related to condom use (Polis et al. 2007). A retrospective 
cross-sectional study from Hong Kong (Loand Ho 2012) involving 9201 women showed positive 
changes in regular contraceptive use after EC provision which was accompanied with proper 
contraceptive counselling.  
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 L
eth
br
idg
e] 
at 
14
:52
 17
 A
pr
il 2
01
6 
Ac
ce
pte
d M
an
us
cri
pt
 
11 
One third of gynecologists in our study were concerned that women with access to EC would be 
prone to initiate sex at a younger age and to have more sexual partners. This was contrary to the 
attitude of pharmacists for whom the majority did not believe that greater access to EC would 
cause greater risk-taking. Such an attitude of pharmacists is similar to the beliefs of 
gynaecologists in the Lawrence et al. (2010) study, and as well as being supported by many other 
studies that have shown no relation between increased availability and use of EC with increase in 
risk-taking behavior or sexually transmitted infections (Polis et al. 2007, Rodrigueza et al. 2013, 
Raymond, Trussell and Polis 2007). This suggests that EC is just one of a multitude of factors 
that may be related to patients' sexual behaviors.  
In comparison with the practice of gynecologists in the USA (Lawrence, Rasinski, Yoon and 
Curlin 2010), the HCPs in our study were more conservative with regard to providing EC. A 
significantly higher proportion of pharmacists than gynecologists (12% vs. 2%, p < .001) would 
not offer EC to anyone under any circumstance. Similar findings have been found in other 
studies, showing that provision of EC is not consistent, even for sexual assault victims (Hussainy 
et al. 2011, Woodell, Bowling, Moracco and Reed 2007). Additional deeper research with 
pharmacists is needed to understand their reasons for this rejection, as well as reevaluation of the 
dispensing regime. 
Half of the HCPs in our study would offer it only after unprotected intercourse, and every third 
HCP would offer it to all women at risk of unplanned pregnancy. This finding is similar to 
pharmacists’ practice in an Australian study (Hussainy et al. 2011) in which 69% of participants 
considered advanced provision of EC, to have it in case it will be needed, unacceptable for any 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 L
eth
br
idg
e] 
at 
14
:52
 17
 A
pr
il 2
01
6 
Ac
ce
pte
d M
an
us
cri
pt
 
12 
women in any circumstance. Although numerous studies have demonstrated that advanced 
provision of EC is safe (Raymond et al. 2006, Schwarz, Gerbert and Gonzales 2008, Jackson, 
Schwarz, Freedman and Darney 2003), no evidence yet exists that it decreases the number of 
unintended pregnancies (Polis et al. 2007, Raymond, Trussell and Polis 2007). However, all of 
these studies were conducted in developed countries with a high prevalence of use of regular 
contraceptives. In Serbia, where this prevalence is low, but the abortion rate is h gh, these 
circumstances make it a great opportunity for EC use. Further research is needed to evaluate the 
possible reduction of public health costs of unintended pregnancy by using EC. 
In the present research, we found a difference between the views of male and female pharmacists 
on EC, which was similar to results from a previous study in the USA (Lawrence, Rasinski, 
Yoon, and Curlin 2010) in which males were more likely to say it increased risky behavior and 
were less likely to offer it. Previously we reported that gynecologists’ attitudes and practice 
regarding contraception and abortions differed among regions in Serbia (Milosavljevic, 
Krajnovic, Bogavac-Stanojevic, and Mitrovic-Jovanovic 2015). Nevertheless, in the present 
study, we found no difference between gynecologists’ views regarding EC in those regions. 
However, a significant difference was observed in pharmacists’ views. In the least developed 
regions, Southern and Eastern Serbia, where gynecologists were more oriented to abortion than 
to contraception (Milosavljevic, Krajnovic, Bogavac-Stanojevic, and Mitrovic-Jovanovic 2015), 
pharmacists did not favor use of EC. These findings may indicate that patients’ needs may go 
unmet, which would require development of a health policy to address these needs. Access to the 
health care system itself should not be influenced by the personal characteristics or beliefs of 
HCPs. Personal attitudes should not be the leading principles in clinical practice, but rather 
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clinical evidence should guide clinical practice. Adequate clinical guidance documents in this 
field are thus necessary. 
This study had limitations which should be considered when interpreting the results. First, the 
relatively low overall response rates could have resulted in participation bias, potentially 
reducing the accuracy and generalizability of the findings. Also, self-reports are imperfect 
indicators, and social desirability and recall biases were possible. Further, the use of a 
convenience sample of gynecologists attending meetings might have resulted in overestimating 
the respondents’ positive attitude to EC because these groups may have been better informed 
about contraception, again potentially reducing the accuracy and generalizability of the findings. 
Finally, the survey questions were developed for this study and were quite nonspecific, which 
could have resulted in misclassification and/or lack of clarity of the findings and their 
interpretation. Further research is needed to examine what HCPs would do in more specific 
situations. 
CONCLUSION 
Although we found that both HCP groups expected that use of EC would reduce the abortion 
rate, significant differences were observed between the beliefs of gynecologists and of 
pharmacists, which suggested the possibility of non-uniform provision of EC. Gynecologists 
were more concerned than pharmacists that EC would cause more risky contraceptive and sexual 
behaviors. However, contrary to their beliefs, a significantly higher proportion of pharmacists 
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than gynecologists would not offer EC, which may indicate a need to reevaluate dispensing 
practices and to establish official practice guidelines. 
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Table 1 Characteristics of the surveyed pharmacists and gynaecologists 
 Pharmacists (N = 452) Gynaecologists (N = 
166) 
p value 
Gender, n (%) 452 152 <.001 
Female 426 (94) 99 (65)  
Male 26 (6) 53 (35)  
Age group (years), n (%) 425 158 <.001 
≤35 160 (38) 5 (3)  
36-50 189 (44) 96 (61)  
≥51 76 (18) 57 (36)  
Partnered status, n (%) 446 158 <.001 
With partner 276 (62) 123 (78)  
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 L
eth
br
idg
e] 
at 
14
:52
 17
 A
pr
il 2
01
6 
Ac
ce
pte
d M
an
us
cri
pt
 
20 
Without partner  170 (38) 35 (22)  
Children, n (%) 448 149 <.001 
Yes 266 (59) 127 (85)  
No 182 (41) 22 (15)  
Region, n (%) 447 156 .108 
Vojvodina  80 (18) 31 (20)  
Belgrade 206 (46) 69 (44)  
Sumadija and Western 
Serbia 
96 (21) 23 (15)  
Southern and Eastern 
Serbia 
65 (15) 33 (21)  
Patients under 18 years, %  11% (SD = 12%)  
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Questions from patients 
under 18 years in one week, 
n (range) 1.5 (0-19) 
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Table 2. Beliefs of HCPs regarding EC 
 Pharmacists 
(n = 452) 
N (%) 
Gynecologists 
( n = 166) 
N  (%) 
 
p value 
Compared with women who are similar but do not have access to emergency contraceptives 
Women who have access to emergency 
contraceptives will have lower rates of unintended 
pregnancy. (agree) 
242 (53) 142 (86) <.001 
Women who have access to emergency 
contraceptives will be less likely to use other 
contraceptive methods. (agree) 
133 (29) 109 (66) <.001 
Giving women or girls access to emergency 
contraceptives will cause them to initiate sexual 
activity at a younger age than if they did not have 
access to emergency contraceptives. (agree) 
84 (19) 62 (37) <.001 
Women who have access to emergency 56 (12) 55 (33) <.001 
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contraceptives 
will have, on average, more sexual partners. (agree) 
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Table 3. Practice of HCPs with respect to EC 
 Pharmacists 
( n = 442) 
 N  (%) 
Gynecologists 
( n = 164) 
N (%) 
p value 
Emergency contraception is offered to all women 
who 
the HCP believes are at risk of unplanned pregnancy. 
142 (32) 61 (37) .210 
Emergency contraception is offered only to women 
who 
say they have had unprotected intercourse. 
232 (52) 91 (55.5) .440 
Emergency contraception is offered only to victims of 
sexual assault. 
16 (4) 9 (5.5) .293 
Emergency contraception is offered to nobody under 
any circumstance. 
52 (12) 3 (2) <.001 
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Table 4. Unadjusted Odds ratios (OR) and Adjusted* odds ratios (aOR) and 95% Confidence 
Intervals (CI) for factors associated with pharmacists’ (n = 452) beliefs regarding EC 
Characteristic OR 95%CI p 
value 
aOR* 95%CI p 
value 
Women will have lower rates of unintended pregnancy 
Region - Vojvodina 1.421 0.644-3.135 .384    
Region - Belgrade 1.404 0.792-2.491 .246    
Region - Sumadija and 
Western Serbia 
1.224 0.591-2.533 .587    
Region -Southern and Eastern 
Serbia 
0.348 0.181-0.672 .002 0.377 0.193-0.737 .004 
Women will be less likely to use other contraceptive methods 
Region - Vojvodina 0.768 0.473-1.249 .287    
Region - Belgrade 0.979 0.671-1.428 .911    
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Region - Sumadija and 
Western Serbia 
0.942 0.593-1.497 .801    
Region -Southern and Eastern 
Serbia 
1.596 0.908-2.804 .104    
Women will initiate sexual activity at a younger age 
Region - Vojvodina 1.199 0.727-1.976 .477    
Region - Belgrade 0.597 0.401-0.889 .011 0.579 0.387-0.865 .008 
Region - Sumadija and 
Western Serbia 
1.383 0.864-2.215 .177    
Region -Southern and Eastern 
Serbia 
1.434 0.827-2.486 .199    
Women will have more sexual partners 
Gender-Male 3.786 1.670-8.582 .001 3.746 1.654-8.483 .002 
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Region - Vojvodina 0.989 0.560-1.747 .969    
Region - Belgrade 0.567 0.361-0.891 .014 0.610 0.385-0.967 .035 
Region - Sumadija and 
Western Serbia 
1.245 0.738-2.101 .411    
Region -Southern and Eastern 
Serbia 
2.122 1.199-3.753 .010 1.890 1.045-3.421 .035 
* Adjusted for gender (female-0, male-1), age (continuous variable), marital status (without 
partner–0, with partner–1) and children (without children-0, having children-1) 
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Table 5. Unadjusted Odds ratios (OR)) and Adjusted* odds ratios (aOR) and 95% Confidence 
Intervals (CI) for factors associated with gynecologists’ (n = 166) beliefs regarding EC 
Characteristic OR 95%CI p value aOR* 95%CI p value 
Gynecologists offer EC to all women they believe are at risk of unplanned pregnancy 
Gender - Male .496 .241-1.018 .056    
Age 0.965 0.781-1.194 .745    
Belief in lower rates of 
unintended pregnancy 
0.887 0.595-1.321 .555    
Gynecologists offer EC only to women who tell them that they have had unprotected intercourse 
Gender - Male 2.069 1.033-4.141 .040 1.650 0.754-3.613 .210 
Age 0.675 0.371-1.230 .199    
Belief in lower rates of 
unintended pregnancy 
0.738 0.502-1.085 .122    
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Gynecologists offer EC only to victims of sexual assault/ to nobody under any circumstances 
Gender - Male 0.771 0.191-3.116 .716    
Age 1.322 0.855-2.143 .209    
Belief in lower rates of 
unintended pregnancy 
2.776 1.573-4.897 <.001 2.825 1.328-6.012 .007 
* Adjusted for gender (female-0, male-1), age (continuous variable), marital status (without 
partner–0, with partner–1) and children (without children-0, having children-1) 
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